Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Northstar Gold Signs MOU with Hunan Nonferrous Ltd. to Develop Gold Resource (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Predictive Oncology Inc POAI

Healthcare Medical Devices
Predictive Oncology Inc. is a knowledge-driven company focused on applying artificial intelligence (AI) to support the development of cancer therapies. The Company operates through three segments: Pittsburgh, Birmingham, and Eagan. Pittsburgh segment provides services, which include the application of artificial intelligence (AI) using its proprietary biobank of 150,000 plus tumor samples. Pittsburgh segment also develops tumor-specific in vitro models for oncology drug discovery and research. Birmingham segment focuses on contract services and research for biopharmaceutical company clients and academic collaborators, focused on solubility improvements, stability studies, and protein production. Specifically, Birmingham provides optimized formulations for vaccines, antibodies, and other protein therapeutics. Eagan segment produces the STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal.


NDAQ:POAI - Post by User

Predictive Oncology Inc
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(65)
•••
Post by Iseneschalon Jul 25, 2024 8:52am
27 Views
Post# 36147619

POAI.....Good news & bad news..I will give u both ; )

POAI.....Good news & bad news..I will give u both ; )Good news.... positive NR this a.m : Currently trading in the PM at $2.20

Predictive Oncology Enters Biomarker Discovery Market After Successful Retrospective Ovarian Cancer Study Yields Compelling Results

2024-07-25 04:00 PT - News Release

 

Expands AI/ML driven offering to include novel oncology biomarker discovery to predict patient outcomes and drug response in oncology

Now for the Bad News...... This is a P.O set up...The dump fest starts now !!!

Read this EDGAR filing & Trade accordingly

sec.gov/Archives/edgar/data/1446159/000117184324003019/s3a_051524.htm

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities